NCT03359044

Brief Summary

Fiberoptic bronchoscopy plays a very important role in the diagnosis and treatment of respiratory diseases in children.In China,this procedure is mainly performed under two different anesthesia methods:sedation and general anesthesia(GA) . Which is better ? there are still a lot of controversies . Several early retrospective studies suggest that, in addition to the possible increase in costs, general anesthesia in intraoperative complications, postoperative recovery and other aspects did not bring significant improvement. But clinically we observed that children under sedation often can not cooperate, they often shows anxiety,restless,crying,and so on, under these situation, some restraint measures may be used, which may have an impact on the child's neuropsychological development. Therefore ,we design this study ,aiming to compare the influence between sedation and general anesthesia (GA) on children 's neuropsychological development.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
290

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Feb 2018

Typical duration for all trials

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 27, 2017

Completed
5 days until next milestone

First Posted

Study publicly available on registry

December 2, 2017

Completed
2 months until next milestone

Study Start

First participant enrolled

February 1, 2018

Completed
2.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 30, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 30, 2020

Completed
Last Updated

January 4, 2018

Status Verified

October 1, 2017

Enrollment Period

2.8 years

First QC Date

November 27, 2017

Last Update Submit

January 2, 2018

Conditions

Keywords

Fiberoptic bronchoscopyNeuropsychological Developmentgeneral anesthesia

Outcome Measures

Primary Outcomes (1)

  • The detection rate of abnormal behavior in both groups

    Using the Achenbach Child Behavior Checklist(CBCL)for Parents.The CBCL is a widely used parent report questionnaire identifying behavioural and emotional problems in children. The CBCL is administered in interview format and respondents are asked to rate 112 problem items as 0 for "not true of the child," 1 for "somewhat or sometimes true of the child," and 2 for "very true or often true of the child", based on the past two months. The raw scores from the 112 items are then compared with age- and gender-matched controls from the standardization sample, and standard scores are then derived with a mean of 50 and a standard deviation of 10. Worst value is 80; best value is 30.

    Three years after operation

Secondary Outcomes (1)

  • Full Scale Intelligence Quotient (FSIQ) Score of the Wechsler Intelligence Scale for Children (WISC)-IV

    Three years after operation

Study Arms (2)

Sedation + topical anesthesia

midazolam 0.1~0.2 mg/kg for sedation, 2%lidocaine for topical anesthesia

General anesthesia+ topical anesthesia

propofol 4~5mg/kg、Remifentanil2~3μg/kg for induction ,insert Laryngeal Mask Airway(LMA) , 2%lidocaine for topical anesthesia

Eligibility Criteria

Age4 Years - 10 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)
Sampling MethodNon-Probability Sample
Study Population

(1)Age 4-10Years;(2)ASAⅠ~Ⅱ;(3)Plan to accept fiberoptic bronchoscopy treatment;(4) lives in the city where the research unit is located;(5)signed informed consent

You may qualify if:

  • Age 4-10 years
  • American society of anesthesiologists(ASA) gradeⅠ~Ⅱ
  • Plan to accept fiberoptic bronchoscopy treatment
  • lives in the city where the research unit is located
  • signed informed consent

You may not qualify if:

  • preterm infants less than 28 weeks of gestational age or preoperative screening found that development, cognitive or behavioral abnormalities
  • known congenital malformations may have a potential impact on the development of children's neuropsychological function
  • known to have central nervous system disorders or meet the diagnostic criteria of Diagnostic and Statistical Manual(DSM) mental illness
  • children with contraindications to intravenous general anesthesia

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

PneumoniaPulmonary AtelectasisCough

Condition Hierarchy (Ancestors)

Respiratory Tract InfectionsInfectionsLung DiseasesRespiratory Tract DiseasesRespiration DisordersSigns and Symptoms, RespiratorySigns and SymptomsPathological Conditions, Signs and Symptoms

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 27, 2017

First Posted

December 2, 2017

Study Start

February 1, 2018

Primary Completion

November 30, 2020

Study Completion

November 30, 2020

Last Updated

January 4, 2018

Record last verified: 2017-10